First live birth before surgical verification of endometriosis-a nationwide register study of 18 324 women.


Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
01 08 2023
Historique:
received: 25 01 2023
revised: 22 05 2023
medline: 3 8 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

Do women with endometriosis have lower first live birth rate before surgical diagnosis than women without verified endometriosis? Compared to reference women, the incidence of first live birth was lower in women prior to surgical verification of endometriosis irrespective of the type of endometriosis. Endometriosis is associated with pain and reduced fertility. The mechanism of infertility is partly explained by anatomical, endocrinological, and immunological changes. Over the past decades, the treatment of both endometriosis and infertility has evolved. Knowledge of fertility far before surgical diagnosis of endometriosis in large cohorts and of different types of endometriosis has been lacking. The diagnostic delay of endometriosis is long, 6-7 years. Retrospective population-based cohort study focused on the time period before the surgical verification of endometriosis. All women with surgical verification of endometriosis in 1998-2012 were identified from the Finnish Hospital Discharge Register and the reference cohort from the Central Population Register. Data on deliveries, gynecological care, and sociodemographic factors before the surgical diagnosis were gathered from Finnish national registers maintained by the Finnish Institute for Health and Welfare, the Digital and Population Data Services Agency, and Statistics Finland. All women aged 15-49 years at the time of surgical verification of endometriosis (ICD-10: N80.1-N80.9) in Finland during 1998-2012 were identified (n = 21 620). Of them, we excluded women born in 1980-1999 due to the proximity of the surgical diagnosis (n = 3286) and women left without reference (n = 10) for the final endometriosis cohort of 18 324 women. From the final cohort, we selected sub-cohorts of women with isolated diagnosis of ovarian (n = 6384), peritoneal (n = 5789), and deep (n = 1267) endometriosis. Reference women were matched by age and residence and lacked registered clinical or surgical diagnosis of endometriosis (n = 35 793). The follow-up started at the age of 15 years and ended at the first birth, sterilization, bilateral oophorectomy, hysterectomy, or until the surgical diagnosis of endometriosis or corresponding index day-whichever came first. Incidence rate (IR) and the incidence rate ratio (IRR) of first live birth before the surgical verification of endometriosis with corresponding CIs were calculated. In addition, we reported the fertility rate of parous women (the number of all children divided by the number of parous women in the cohort) until the surgical verification of endometriosis. The trends in first births were analysed according to the women's birth cohort, type of endometriosis, and age. Surgical diagnosis of endometriosis was set at the median age of 35.0 years (IQR 30.0-41.4). Altogether 7363 women (40.2%) with endometriosis and 23 718 (66.3%) women without endometriosis delivered a live born infant before the index day (surgery). The IRs of the first live birth per 100 person-years were 2.64 (95% CI 2.58-2.70) in the endometriosis cohort and 5.21 (95% CI 5.15-5.28) in the reference cohort. Between the endometriosis sub-cohorts, the IRs were similar. The IRR of the first live birth was 0.51 (95% CI 0.49-0.52) between the endometriosis and reference cohorts. Fertility rate per parous woman before the surgical diagnosis was 1.93 (SD 1.00) and 2.16 (SD 1.15) in the endometriosis and reference cohorts (P < 0.01). The median age at the first live birth was 25.5 (IQR 22.3-28.9) and 25.5 (IQR 22.3-28.6) years (P = 0.01), respectively. Between the endometriosis sub-cohorts, women in the ovarian sub-cohort were the oldest at the time of surgical diagnosis with the median age of 37.2 years (IQR 31.4-43.3), (P < 0.001). Altogether 44.1% (2814) of the women with ovarian, 39.4% (2282) with peritoneal, and 40.8% (517) with deep endometriosis delivered a live born infant before the diagnosis. IRRs between the endometriosis sub-cohorts did not differ. Fertility rate per parous woman was lowest, 1.88 (SD 0.95), in the ovarian sub-cohort compared to 1.98 (SD 1.07) in the peritoneal and 2.04 (SD 0.96) in deep endometriosis (P < 0.001). Women with ovarian endometriosis were oldest at first live birth compared to women in other sub-cohorts with a median age of 25.8 years (IQR 22.6-29.1) (P < 0.001). Cumulative distributions of first live birth were presented according to age at first live birth and birth cohorts of the participants. The increasing age at first live birth, increasing practice of clinical diagnostics, conservative treatment of endometriosis, a possible effect of coexisting adenomyosis, and use of artificial reproductive treatments should be considered when assessing the results. In addition, the study is limited due to possible confounding effects of socioeconomic factors, such as level of education. It should be noted that, in this study, we assessed parity only during the years preceding the surgical verification of endometriosis. The need for early diagnosis and relevant treatment of endometriosis appears clear given the impairment of fertility prior to its surgical verification. The study was funded by the Hospital District of Helsinki and Uusimaa and by Finska Läkaresällskapet. The authors report no conflicts of interest. All authors have completed the ICMJE Disclosure form. N/A.

Identifiants

pubmed: 37403272
pii: 7218807
doi: 10.1093/humrep/dead120
pmc: PMC10391315
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1520-1528

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.

Références

J Minim Invasive Gynecol. 2020 Feb;27(2):390-407.e3
pubmed: 31676397
Hum Reprod. 2022 Jun 30;37(7):1470-1479
pubmed: 35460419
Fertil Steril. 2020 Feb;113(2):374-382.e2
pubmed: 32106991
Fertil Steril. 2011 Aug;96(2):366-373.e8
pubmed: 21718982
J Minim Invasive Gynecol. 2019 Feb;26(2):299-311.e3
pubmed: 30717864
Scand J Soc Med. 1995 Mar;23(1):75-80
pubmed: 7784857
N Engl J Med. 2020 Mar 26;382(13):1244-1256
pubmed: 32212520
J Womens Health (Larchmt). 2016 Oct;25(10):1021-1029
pubmed: 27379997
Sci Rep. 2021 Oct 14;11(1):20404
pubmed: 34650132
Am J Obstet Gynecol. 2019 Mar;220(3):230-241
pubmed: 30419199
Hum Reprod. 2017 Aug 1;32(8):1732-1742
pubmed: 28591798
Acta Obstet Gynecol Scand. 2014 May;93(5):483-9
pubmed: 24617701
Acta Obstet Gynecol Scand. 2018 Jan;97(1):59-67
pubmed: 29028285
Hum Reprod Update. 2016 Jan-Feb;22(1):70-103
pubmed: 26450609
Fertil Steril. 2016 Jul;106(1):164-171.e1
pubmed: 27060727
Eur J Contracept Reprod Health Care. 2012 Dec;17(6):468-81
pubmed: 23157704
Hum Reprod. 2021 Nov 18;36(12):3074-3082
pubmed: 34610108
Acta Obstet Gynecol Scand. 2022 Nov;101(11):1245-1252
pubmed: 36056916
J Obstet Gynaecol Can. 2010 Jul;32(7 Suppl 2):S1-32
pubmed: 21545757
Hum Reprod. 2018 Sep 1;33(9):1669-1676
pubmed: 30052994
Hum Reprod Update. 2019 Sep 11;25(5):592-632
pubmed: 31318420
Hum Reprod Open. 2022 Feb 26;2022(2):hoac009
pubmed: 35350465
Hum Reprod. 2018 Oct 1;33(10):1854-1865
pubmed: 30239732
Inform Health Soc Care. 2018 Sep;43(3):310-319
pubmed: 28388252
Hum Reprod. 2018 Jul 1;33(7):1205-1211
pubmed: 29741687
Hum Reprod. 2022 Sep 30;37(10):2350-2358
pubmed: 36018266
Reprod Biomed Online. 2021 Jan;42(1):185-206
pubmed: 33191131
Acta Obstet Gynecol Scand. 2017 Jun;96(6):688-693
pubmed: 28419418
Oncotarget. 2017 Jul 18;8(29):46928-46936
pubmed: 28159926
Gynecol Obstet Invest. 2021;86(4):315-335
pubmed: 34352799
Eur J Obstet Gynecol Reprod Biol. 2017 Feb;209:86-94
pubmed: 27342685
Cochrane Database Syst Rev. 2020 Oct 23;10:CD011031
pubmed: 33095458
Eur J Popul. 2018 Jun 19;35(3):563-586
pubmed: 31372105
Lancet. 2021 Feb 27;397(10276):839-852
pubmed: 33640070
Acta Obstet Gynecol Scand. 2021 Jul;100(7):1248-1257
pubmed: 33550615
Eur J Contracept Reprod Health Care. 2011 Apr;16(2):108-15
pubmed: 21281094
Scand J Public Health. 2012 Aug;40(6):505-15
pubmed: 22899561
Hum Reprod. 2003 Apr;18(4):756-9
pubmed: 12660267
Hum Reprod Update. 2012 May-Jun;18(3):248-59
pubmed: 22371314

Auteurs

A Tuominen (A)

Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Obstetrics and Gynecology, Hyvinkää Hospital, Hyvinkää, Finland.

L Saavalainen (L)

Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

M Niinimäki (M)

Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
Medical Research Center Oulu (MRC Oulu), University of Oulu, Oulu University Hospital, Wellbeing Services County of North Ostobothnia, Oulu, Finland.

M Gissler (M)

Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Academic Primary Health Care Center, Stockholm, Sweden.

A But (A)

Department of Biostatistics, University of Helsinki, Helsinki, Finland.

P Härkki (P)

Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

O Heikinheimo (O)

Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH